Development and Challenges of Synthetic Retinoid Formulations in Cancer

被引:10
作者
Assi, Sara [1 ]
El Hajj, Hiba [2 ]
Hayar, Berthe [3 ]
Pisano, Claudio [4 ]
Saad, Walid [5 ]
Darwiche, Nadine [3 ]
机构
[1] Amer Univ Beirut, Maroun Semaan Fac Engn & Architecture, Dept Biomed Engn, Beirut, Lebanon
[2] Amer Univ Beirut, Fac Med, Dept Expt Pathol Immunol & Microbiol, Beirut, Lebanon
[3] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, POB 11-0236, Beirut 11072020, Lebanon
[4] Inst Mol Biol & Genet, Biogem, Via Camporeale, I-83031 Ariano Irpino, AV, Italy
[5] Amer Univ Beirut, Maroun Semaan Fac Engn & Architecture, Dept Chem Engn, POB 11-0236, Beirut 11072020, Lebanon
关键词
Synthetic retinoid; delivery system; formulation; development; drug; cancer; MYELOID-LEUKEMIA CELLS; ACUTE PROMYELOCYTIC LEUKEMIA; RECEPTOR AGONIST BEXAROTENE; X-RECEPTOR; ANTITUMOR-ACTIVITY; PLGA MICROSPHERES; SOLID DISPERSIONS; RESISTANT NEUROBLASTOMA; THERAPEUTIC-EFFICACY; SURFACE MODIFICATION;
D O I
10.2174/1567201819666220810094708
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Retinoids represent a class of chemical compounds derived from or structurally and functionally related to vitamin A. Retinoids play crucial roles in regulating a range of crucial biological processes spanning embryonic development to adult life. These include regulation of cell proliferation, differentiation, and cell death. Due to their promising characteristics, retinoids emerged as potent anti-cancer agents, and their effects were validated in vitro and in vivo preclinical models of several solid and hematological malignancies. However, their clinical translation remained limited due to poor water solubility, photosensitivity, short half-life, and toxicity. The development of retinoid delivery formulations was extensively studied to overcome these limitations. This review will summarize some preclinical and commercial synthetic retinoids in cancer and discuss their different delivery systems.
引用
收藏
页码:1314 / 1326
页数:13
相关论文
共 127 条
[1]  
Abdel-Samad R, 2018, AM J CANCER RES, V8, P39
[2]   Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia [J].
Ablain, Julien ;
de The, Hugues .
INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (10) :2262-2272
[3]   Nanoparticles in the clinic: An update post COVID-19 vaccines [J].
Anselmo, Aaron C. ;
Mitragotri, Samir .
BIOENGINEERING & TRANSLATIONAL MEDICINE, 2021, 6 (03)
[4]   Antitumor activities of the synthetic retinoid ST1926 in two-dimensional and three-dimensional human breast cancer models [J].
Aouad, Patrick ;
Saikali, Melody ;
Abdel-Samad, Rana ;
Fostok, Sabreen ;
El-Houjeiri, Leeanna ;
Pisano, Claudio ;
Talhouk, Rabih ;
Darwiche, Nadine .
ANTI-CANCER DRUGS, 2017, 28 (07) :757-770
[5]   The synthetic retinoid ST1926 attenuates prostate cancer growth and potentially targets prostate cancer stem-like cells [J].
Bahmad, Hisham F. ;
Samman, Houda ;
Monzer, Alissar ;
Hadadeh, Ola ;
Cheaito, Katia ;
Abdel-Samad, Rana ;
Hayar, Berthe ;
Pisano, Claudio ;
Msheik, Hiba ;
Liu, Yen-Nien ;
Darwiche, Nadine ;
Abou-Kheir, Wassim .
MOLECULAR CARCINOGENESIS, 2019, 58 (07) :1208-1220
[6]   Doxil® - The first FDA-approved nano-drug: Lessons learned [J].
Barenholz, Yechezkel .
JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) :117-134
[7]   The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma [J].
Basma, Hussein ;
Ghayad, Sandra E. ;
Rammal, Ghina ;
Mancinelli, Angelo ;
Harajly, Mohammad ;
Ghamloush, Farah ;
Dweik, Loai ;
El-Eit, Rabab ;
Zalzali, Hassan ;
Rabeh, Wissam ;
Pisano, Claudio ;
Darwiche, Nadine ;
Saab, Raya .
INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (06) :1528-1537
[8]   Nuclear retinoid receptors and the transcription of retinoid-target genes [J].
Bastien, J ;
Rochette-Egly, C .
GENE, 2004, 328 :1-16
[9]   Retinoid treatment of skin diseases [J].
Beckenbach, Lisa ;
Baron, Jens M. ;
Merk, Hans F. ;
Loeffler, Harald ;
Amann, Philipp M. .
EUROPEAN JOURNAL OF DERMATOLOGY, 2015, 25 (05) :384-391
[10]   Retinoids Delivery Systems in Cancer: Liposomal Fenretinide for Neuroectodermal-Derived Tumors [J].
Bensa, Veronica ;
Calarco, Enzo ;
Giusto, Elena ;
Perri, Patrizia ;
Corrias, Maria Valeria ;
Ponzoni, Mirco ;
Brignole, Chiara ;
Pastorino, Fabio .
PHARMACEUTICALS, 2021, 14 (09)